News Focus
News Focus
Followers 4
Posts 1446
Boards Moderated 0
Alias Born 10/03/2015

Re: jondoeuk post# 983

Sunday, 05/24/2026 12:09:58 PM

Sunday, May 24, 2026 12:09:58 PM

Post# of 997
They can't finish P1 dosing study by June if they didn't focus on tumor type and regiment. MSS CRC and Cetuximab + FT839 was chosen before P1 started.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News